Mary Elizabeth Kleingarn Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 13603 80th Circle North, Maple Grove, MN 55369 Phone: 763-274-3120 |
Euniah M Onserio Marriage & Family Therapist Medicare: Medicare Enrolled Practice Location: 13603 80th Cir N, Maple Grove, MN 55369 Phone: 763-274-3120 Fax: 763-274-3121 |
Amber Wentzel Marriage & Family Therapist Medicare: Medicare Enrolled Practice Location: 13603 80th Circle North, Maple Grove, MN 55369 Phone: 763-416-1489 |
Trisha Lynne Mckeever, MA, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 7084 E Fish Lake Rd, Maple Grove, MN 55311 Phone: 612-703-6267 |
Jeri Tongen Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 13603 80th Cir N, Maple Grove, MN 55369 Phone: 763-416-1489 Fax: 763-416-3957 |
Ms. Kathleen A O'brien, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 7270 Forestview Ln N Ste 150, Maple Grove, MN 55369 Phone: 763-416-4167 Fax: 763-416-4137 |
Ms. Joanne M Finnegan, MA, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 11334 86th Ave N, Maple Grove, MN 55369 Phone: 763-255-2125 Fax: 763-255-2126 |
Clair Elizabeth Stangle Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 13603 80th Cir N, Maple Grove, MN 55369 Phone: 763-274-3120 Fax: 763-274-3121 |
News Archive
InfoLogix, Inc. ("InfoLogix" or the "Company"), a leading technology provider of enterprise mobility solutions for the healthcare and commercial industries, today announced that it has filed a preliminary proxy statement with the U.S. Securities and Exchange Commission ("SEC") in connection with a special meeting of stockholders of InfoLogix to approve a proposed recapitalization plan of the Company and certain related matters.
A previous study of mortality rates for congenital heart surgery used routinely available hospital data that were misleading, according to a report published on bmj.com which questions the validity of such data being made public.
Genticel, a French biotechnology company and developer of innovative immunotherapies to prevent cancers caused by the human papillomavirus, today announces that the US Food and Drug Administration (FDA) has cleared Genticel's Investigational New Drug application to conduct in the US a phase 1 clinical study of GTL001 in patients infected with HPV 16 and/or 18, the two HPV types responsible for 70% of cervical cancer cases.
Toddlers living in socially-deprived areas are at the greatest risk of suffering a scald in the home, researchers at The University of Nottingham have found. The study, published in the journal Burns, showed that boys aged between one and two years old and those with multiple siblings were statistically more likely to suffer a hot water-related injury, while children born to mothers aged 40 years and over were at less risk than those with teenage mums.
› Verified 5 days ago